In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part
of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to …

Introduction Viral vectors have proven useful for delivering genetic information, such as
drugs and vaccines, for therapeutic and prophylactic interventions. Self-amplifying RNA …

Lassa fever is a zoonotic disease identified by the World Health Organization (WHO) as
having pandemic potential. This study estimates the health-economic burden of Lassa fever …

Rodents are ubiquitous and typically unwelcome dwellers in human habitats worldwide,
infesting homes, farm fields, and agricultural stores and potentially shedding disease …

Viral haemorrhagic fevers encompass a diverse group of severe, often life-threatening
illnesses caused by viruses from multiple families, including Arenaviridae, Filoviridae …

Annual outbreaks of Lassa fever have resulted in a public health threat in Nigeria and other
endemic countries in Sub-Saharan Africa. While the Lassa Virus (LASV) is endemic in …

Lassa Fever is a deadly viral haemorrhagic disease, causing annually several hundreds of
deaths in West Africa. This zoonotic disease is primarily transmitted to humans by rodents of …

ABSTRACT The Natal multimammate mouse (Mastomys natalensis) is the host of Lassa
mammarenavirus, causing Lassa haemorrhagic fever in West Africa. As there is currently no …

Mammarenaviruses (also known simply as arenaviruses) originate primarily in rodents and
are divided into Old World (OW) and New World (NW) groups based on their geographical …

Lassa virus, the cause of deadly Lassa fever, is endemic in West Africa, where thousands of
cases occur on an annual basis. Nigeria continues to report increasingly severe outbreaks …